Unknown

Dataset Information

0

Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles.


ABSTRACT: Regulating molecular interactions in the T-cell synapse to prevent autoimmunity or, conversely, to boost anti-tumor immunity has long been a goal in immunotherapy. However, delivering therapeutically meaningful doses of immune-modulating compounds into the synapse represents a major challenge. Here, we report that covalent coupling of maleimide-functionlized nanoparticles (NPs) to free thiol groups on T-cell membrane proteins enables efficient delivery of compounds into the T-cell synapse. We demonstrate that surface-linked NPs are rapidly polarized toward the nascent immunological synapse (IS) at the T-cell/APC contact zone during antigen recognition. To translate these findings into a therapeutic application we tested the NP delivery of NSC-87877, a dual inhibitor of Shp1 and Shp2, key phosphatases that downregulate T-cell receptor activation in the synapse, in the context of adoptive T cell therapy of cancer. Conjugating NSC-87877-loaded NPs to the surface of tumor-specific T cells just prior to adoptive transfer into mice with advanced prostate cancer promoted a much greater T-cell expansion at the tumor site, relative to co-infusing the same drug dose systemically, leading to enhanced survival of treated animals. In summary, our studies support the application of T-cell-linked synthetic NPs as efficient drug delivery vehicles into the IS, as well as the broad applicability of this new paradigm for therapeutically modulating signaling events at the T-cell/APC interface.

SUBMITTER: Stephan MT 

PROVIDER: S-EPMC3395588 | biostudies-literature | 2012 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles.

Stephan Matthias T MT   Stephan Sirkka B SB   Bak Peter P   Chen Jianzhu J   Irvine Darrell J DJ  

Biomaterials 20120515 23


Regulating molecular interactions in the T-cell synapse to prevent autoimmunity or, conversely, to boost anti-tumor immunity has long been a goal in immunotherapy. However, delivering therapeutically meaningful doses of immune-modulating compounds into the synapse represents a major challenge. Here, we report that covalent coupling of maleimide-functionlized nanoparticles (NPs) to free thiol groups on T-cell membrane proteins enables efficient delivery of compounds into the T-cell synapse. We de  ...[more]

Similar Datasets

2011-12-31 | GSE23118 | GEO
| S-EPMC4973867 | biostudies-literature
| S-EPMC2570783 | biostudies-literature
| S-EPMC7698888 | biostudies-literature
| S-EPMC7329883 | biostudies-literature
| S-EPMC3059367 | biostudies-literature
2011-12-31 | E-GEOD-23118 | biostudies-arrayexpress